Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histiocytoses

J L Stéphan1

  • 1Unité d'Hématologie et Oncologie Pédiatrique, Hôpital Nord, Centre Hospitalier Universitaire, Saint Etienne, France.

European Journal of Pediatrics
|August 1, 1995
PubMed
Summary

Childhood histiocytoses, rare disorders affecting children, encompass Langerhans cell histiocytosis and hemophagocytic syndromes. Research suggests Langerhans cell histiocytosis is a clonal disease, while class II histiocytoses share immune features involving cytokine release.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rifabutin-associated uveitis in a 10-year-old child with HIV: Case report and review of the literature.

Journal francais d'ophtalmologie·2018
Same author

Second malignant neoplasm following childhood cancer: A nested case-control study of a recent cohort (1987-2004) from the Childhood Cancer Registry of the Rhône-Alpes region in France.

Pediatric hematology and oncology·2016
Same author

Surgical management of thymic epithelial tumors in children: lessons from the French Society of Pediatric Oncology and review of the literature.

Pediatric blood & cancer·2014
Same author

Cardiac tamponade in a child with systemic-onset juvenile idiopathic arthritis: dramatic improvement after interleukin-1 blockade by anakinra.

Pediatric cardiology·2011
Same author

[Current events in vaccination].

Medecine et maladies infectieuses·2011
Same author

[Epidemiology of autoimmune haemolytic anemia in children: French data].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2006

Area of Science:

  • Pediatric Hematology/Oncology
  • Immunology
  • Pathology

Background:

  • Childhood histiocytoses represent a rare, heterogeneous group of disorders.
  • These conditions present with diverse clinical manifestations and pathological features.
  • Understanding their pathogenesis and immunopathology is crucial for effective management.

Purpose of the Study:

  • To review the clinical, pathological, and immunopathological characteristics of childhood histiocytoses.
  • To explore the current understanding of the pathogenesis of Langerhans cell histiocytosis.
  • To differentiate between class I and class II histiocytoses and their underlying mechanisms.

Main Methods:

  • Literature review focusing on clinical, pathological, and immunopathological studies.
  • Analysis of recent findings regarding the clonal nature of Langerhans cell histiocytosis.
  • Comparison of clinicopathological features of familial erythrophagocytic lymphohistiocytosis and reactive hemophagocytic syndromes.

Main Results:

  • Langerhans cell histiocytosis (class I) is increasingly recognized as a clonal histiocytic disease.
  • Class II histiocytoses, including familial erythrophagocytic lymphohistiocytosis and reactive hemophagocytic syndromes, share common immunological features.
  • These shared features involve uncontrolled T-cell cytokine release, leading to macrophage activation and hemophagocytosis.

Conclusions:

  • Childhood histiocytoses require a comprehensive understanding of their diverse clinical and pathological spectra.
  • Langerhans cell histiocytosis exhibits characteristics of a clonal disorder.
  • Class II histiocytoses are linked by a common pathway of immune dysregulation involving cytokine storms.

Related Experiment Videos